Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-11-15 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges about a scheduled group meeting with institutional investors and analysts. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures of material events. The content is an announcement of an upcoming investor meeting, not a financial report or transcript. The document length is only 1834 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-11-15 English
Newspaper Advertisements
Regulatory Filings
2022-11-12 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a transcript of a Q2 FY'23 earnings conference call for Heranba Industries Limited held on November 8, 2022. It includes detailed discussions of quarterly financial results, revenue, EBITDA, profit after tax, capacity utilization, capex, market conditions, and future guidance. The presence of a moderator, management speakers, and Q&A session confirms it is a full transcript of an earnings call. The content focuses on quarterly financial performance and outlook, which aligns with the definition of a Call Transcript (CT). The document length (15,000 characters) and detailed financial discussion further support this classification rather than a brief earnings release or report publication announcement.
2022-11-12 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of an earnings conference call held on November 8, 2022. It references the financial results for the quarter and half year ended September 30, 2022, but does not contain the transcript or detailed financial data itself. Instead, it provides a link to the audio recording on the company's website. The document is short (1286 characters) and serves as an announcement of the availability of the call recording rather than the call transcript itself. Therefore, it should be classified as a Call Transcript (CT) related announcement, but since it does not contain the transcript text, it is best classified as a Regulatory Filing (RNS) as a general announcement about the call recording availability.
2022-11-08 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the second quarter and six months ended September 30, 2022, for Heranba Industries Limited. It includes key financial metrics such as revenues, EBITDA, and PAT, along with management commentary on performance and outlook. The document is approximately 4,824 characters long, which is typical for an earnings release. It does not contain full financial statements or detailed analysis typical of an Interim/Quarterly Report (IR), nor is it a full Annual Report (10-K). It is not a regulatory filing, certification, or announcement of a report publication. The presence of quarterly financial highlights and management comments aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER) with high confidence. Q2 2023
2022-11-08 English
Resignation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges and the board of directors, dated November 8, 2022. It details the resignation of two directors from the company's board, including an Independent Director and an Executive Director. The document includes resignation letters, confirmations of no other material reasons for resignation, and requests for formalities to be completed. The content focuses exclusively on changes in the company's board of directors and does not contain financial data, audit information, or other report types. The presence of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures related to board and management changes, further supports this classification. Therefore, this document fits the category of Board/Management Information (MANG).
2022-11-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.